Aciclovir-resistant herpes keratitis

Clinical and Experimental Ophthalmology

Volumn 38, Issue 3, 2010, Pages 309-313

  Choong, Keat ^a   Walker, Nathan J ^a   Apel, Andrew JG ^a   Whitby, Michael ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Aciclovir resistant; Foscarnet; Herpes simplex virus; Keratitis

Indexed keywords

ACICLOVIR; FOSCARNET; VALACICLOVIR;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORNEA DISEASE; CORNEA NEOVASCULARIZATION; CORNEA TRANSPLANTATION; CORNEA ULCER; CREATININE CLEARANCE; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG SENSITIVITY; DRUG TREATMENT FAILURE; FEMALE; GRAFT REJECTION; HERPES SIMPLEX KERATITIS; HUMAN; HUMAN TISSUE; KERATOPLASTY; MALE; RECURRENT INFECTION; SCAR FORMATION; SYSTEMIC THERAPY; ULCER HEALING; WOUND HEALING;

ACYCLOVIR; ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; AGED, 80 AND OVER; ANTIVIRAL AGENTS; BLINDNESS; DRUG RESISTANCE, VIRAL; HUMANS; KERATITIS, HERPETIC; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 77953227600     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2010.02209.x     Document Type: Article

References (30)

1. Liesegang TJ. Herpes simplex virus epidemiology and ocular importance. Cornea 2001, 20:1-13.
2. Barron BA, Gee L, Hauck WW. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology 1994, 101:1871-82. Herpetic Eye Disease Study
3. Wilhelmus KR, Gee L, Hauck WW. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology 1994, 101:1883-95. Herpetic Eye Disease Study, discussion 1895-6
4. Sozen E, Avunduk AM, Akyol N. Comparison of efficacy of oral valacyclovir and topical acyclovir in the treatment of herpes simplex keratitis: a randomized clinical trial. Chemotherapy 2006, 52:29-31.
5. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N Engl J Med 1998, 339:300-6. Herpetic Eye Disease Study Group
6. Miserocchi E, Modorati G, Galli L, Rama P. Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study. Am J Ophthalmol 2007, 144:547-51.
7. Itahashi M, Higaki S, Shimomura Y. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1. Semin Ophthalmol 2008, 23:241-7.
8. Liesegang TJ, Melton LJ, Daly PJ, Ilstrup DM. Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 1989, 107:1155-9.
9. Predictors of recurrent herpes simplex virus keratitis. Cornea 2001, 20:123-8. Herpetic Eye Disease Study Group
10. Gilbert C, Bestman-Smith J, Boivin G. Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms. Drug Resist Updat 2002, 5:88-114.
11. Fife KH, Crumpacker CS, Mertz GJ, Hill EL, Boone GS. Recurrence and resistance patterns of herpes simplex virus following cessation of > or =6 years of chronic suppression with acyclovir. J Infect Dis 1994, 169:1338-41. Acyclovir Study Group
12. Christophers J, Clayton J, Craske J. Survey of resistance of herpes simplex virus to acyclovir in northwest England. Antimicrob Agents Chemother 1998, 42:868-72.
13. Bacon TH, Levin MJ, Leary JJ, Sarisky RT, Sutton D. Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin Microbiol Rev 2003, 16:114-28.
14. Stránská R, Schuurman R, Nienhuis E. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization. J Clin Virol 2005, 32:7-18.
15. Ziyaeyan M, Alborzi A, Japoni A. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome. Int J Dermatol 2007, 46:1263-6.
16. Reyes M, Shaik NS, Graber JM. Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics. Arch Intern Med 2003, 163:76-80.
17. Charles SJ, Gray JJ. Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease. Br J Ophthalmol 1990, 74:286-8.
18. Duan R, de Vries RD, Osterhaus AD, Remeijer L, Verjans GM. Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis. J Infect Dis 2008, 198:659-63.
19. Balfour HH, Benson C, Braun J. Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. J Acquir Immune Defic Syndr 1994, 7:254-60.
20. Pratuangtham S, Bornstein SM, Boyer KM, McAuley JB, Deutsch TA, Gotoff SP. Treatment of acyclovir-resistant herpes simplex virus keratitis in a patient with Wiskott-Aldrich syndrome. Clin Infect Dis 1997, 25:1257-8.
21. Alvarez-McLeod A, Havlik J, Drew KE. Foscarnet treatment of genital infection due to acyclovir-resistant herpes simplex virus type 2 in a pregnant patient with AIDS: case report. Clin Infect Dis 1999, 29:937-8.
22. Arevalo JF, Gonzalez C, Capparelli EV. Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitis. J Infect Dis 1995, 172:951-6.
23. Levin MJ, Bacon TH, Leary JJ. Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients. Clin Infect Dis 2004, 39(5):S248-57. Suppl
24. Sarisky RT, Cano R, Nguyen TT. Biochemical characterization of a virus isolate, recovered from a patient with herpes keratitis, that was clinically resistant to acyclovir. Clin Infect Dis 2001, 33:2034-9.
25. Fabricius EM. Foscarnet eyedrops in recurrence prophylaxis of herpes simplex virus keratitis. Acta Ophthalmol Scand 1998, 76:755-7.
26. Behrens-Baumann W. Phosphonoformate (foscarnet, PFA) versus trifluorthymidine in the treatment of keratitis dendritica in the human. A double-blind, randomized, preliminary trial. Acta Ophthalmol 1992, 70:690-2.
27. Wilhelmus KR. Therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev 2008, Issue 1:CD002898.
28. Kaufman HE, Varnell ED, Thompson HW. Trifluridine, cidofovir, and penciclovir in the treatment of experimental herpetic keratitis. Arch Ophthalmol 1998, 116:777-80.
29. Boisjoly HM, Park NH, Pavan-Langston D, De Clercq E. Herpes simplex acyclovir-resistant mutant in experimental keratouveitis. Arch Ophthalmol 1983, 101:1782-6.
30. Meerbach A, Wutzler P, Gruhn B. Brivudin (ZostexR) in the treatment of herpes zoster in immunosuppressed patients. Antiviral Res 2007, 74:A75-A75.